SMAS Somatic Systems Inc (CE)

Somatic Systems, Inc. (PINKSHEETS: SMAS) announced that it has released its most recent financial reports, bringing its financial reporting status current on Pink Sheets. These releases exceed the standards for Pink Sheets' rating for Limited Information, removing the "Stop Sign" symbol from the company's Pink Sheets listing, and providing the company with the second highest rating for the Pink Sheets market.

The reports include the company's current first fiscal quarter and the previous fiscal year. Earnings were comparable with the previous year, showing the typical fluctuation per quarter due to yearly variations in the fiscal quarters in which the company collects tuition revenue for its Professional Training Program.

"We are pleased to report a fiscal stability during the worst economic times in decades," stated company CEO Steven Aronstein. "Furthermore, we are excited about the opportunities we have nurtured over the past year, such as pain treatment services for the US military, increased production and international distribution of our self-help products, and expansion of clinic and training operations... At a time when other companies are contracting or closing down altogether, we are facing record expansion opportunities."

The company filed its financial reports with Pink Sheets as part of its efforts to achieve full reporting status on the Pink Sheets to obtain the highest rating on Pink Sheets. This effort is also part of Somatic Systems' current efforts to complete full reporting status with the SEC and uplist the company to the OTC Bulletin Board stock exchange and higher.

About Somatic Systems, Inc.

Somatic Systems is the worldwide center for Clinical Somatics(TM), the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques -- conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day -- to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics(TM) also provides performance gains and injury prevention for casual and professional athletes.

Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources, and opportunities, at www.somatics.org.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact: For more information visit http://www.somatics.org or contact: Investor Relations 1 877 586-2555